Literature DB >> 3264821

Epidemiology of toxoplasmosis among pregnant women in the Paris area.

D Jeannel1, G Niel, D Costagliola, M Danis, B M Traore, M Gentilini.   

Abstract

A survey was performed using a sample of pregnant women selected at one of the biggest test centres in the Paris area. These women were serologically screened for toxoplasmosis between October 1981 and September 1983 (according to the prevention protocol for congenital toxoplasmosis established by the French health ministry). The prevalence rate of specific antibodies for toxoplasmosis was estimated from the 1074 women who were tested for the first time during the study. The prevalence rate among pregnant women in the Paris area was derived by direct standardization according to age and geographical origin. A standardized prevalence rate of 71% +/- 4% among French women, of 51.4% +/- 5% among immigrant women and a global adjusted prevalence rate of 67.3% +/- 3% for pregnant women in the Paris area was found. An incidence rate of 1.6% was estimated for the 2216 non-immune pregnant women included in the sample. There is no significant difference between the probabilities of seroconversion among French and immigrant women (2.3% +/- 1% and 1.6% +/- 0.8% respectively). Comparison of the data with previous study results show a decrease in the prevalence rate of specific antibodies for toxoplasmosis in the Paris area over the last 20 years that cannot be explained by changes in age and geographical origin. No data were available to support an aetiological hypothesis for a decrease in toxoplasma transmission to humans. Since immigration and a decrease in toxoplasma transmission to humans has led to a larger population of women at risk of infection during pregnancy in France, it is therefore important to perform studies to investigate risk factors and markers of acquired toxoplasmosis during pregnancy in order to improve the prevention of congenital toxoplasmosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264821     DOI: 10.1093/ije/17.3.595

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  11 in total

1.  Prevalence of anti-Toxoplasma gondii antibodies in the population of the area of Parma (Italy).

Authors:  P P Valcavi; A Natali; L Soliani; S Montali; G Dettori; C Cheezi
Journal:  Eur J Epidemiol       Date:  1995-06       Impact factor: 8.082

2.  Risk factors for Toxoplasma infection in a reproductive age female population in the area of Belgrade, Yugoslavia.

Authors:  B Bobić; I Jevremović; J Marinković; D Sibalić; O Djurković-Djaković
Journal:  Eur J Epidemiol       Date:  1998-09       Impact factor: 8.082

3.  The role of DNA microarrays in Toxoplasma gondii research, the causative agent of ocular toxoplasmosis.

Authors:  Kevin M Brown; Ira J Blader
Journal:  J Ocul Biol Dis Infor       Date:  2009-12-12

4.  Comparative study on toxoplasma serology among HIV positive and HIV negative illicit drug users in Ahvaz, Iran.

Authors:  Seyed Mohammad Alavi; Ramin Jamshidian; Shokrolah Salmanzadeh
Journal:  Caspian J Intern Med       Date:  2013

Review 5.  Parasites and the hygiene hypothesis: regulating the immune system?

Authors:  Maria Yazdanbakhsh; Paolo M Matricardi
Journal:  Clin Rev Allergy Immunol       Date:  2004-02       Impact factor: 8.667

6.  Seroepidemiology of Toxoplasma gondii infection in Isfahan province, central Iran: A population based study.

Authors:  Sayed Nasser Mostafavi; Behrooz Ataei; Zari Nokhodian; Majid Yaran; Anahita Babak
Journal:  J Res Med Sci       Date:  2011-04       Impact factor: 1.852

7.  Seroepidemiology of Toxoplasma gondii infection in pregnant women in a public hospital in northern Mexico.

Authors:  Cosme Alvarado-Esquivel; Antonio Sifuentes-Alvarez; Sergio Guadalupe Narro-Duarte; Sergio Estrada-Martínez; Juan Humberto Díaz-García; Oliver Liesenfeld; Sergio Arturo Martínez-García; Arturo Canales-Molina
Journal:  BMC Infect Dis       Date:  2006-07-13       Impact factor: 3.090

8.  Seroprevalence of Anti-Toxoplasma gondii Antibodies Among Pregnant Woman in South Khuzestan, Iran.

Authors:  Mohammad Jafar Yad Yad; Nabi Jomehzadeh; Maryam Jafar Sameri; Nooshin Noorshahi
Journal:  Jundishapur J Microbiol       Date:  2014-05-01       Impact factor: 0.747

9.  Toxoplasma gondii infection in women of childbearing age of Isfahan, Iran: A population-based study.

Authors:  Nasser Mostafavi; Behrooz Ataei; Zari Nokhodian; Leila J Monfared; Majid Yaran; Mehdi Ataie; Anahita Babak
Journal:  Adv Biomed Res       Date:  2012-08-28

10.  Metabolic reconstruction identifies strain-specific regulation of virulence in Toxoplasma gondii.

Authors:  Carl Song; Melissa A Chiasson; Nirvana Nursimulu; Stacy S Hung; James Wasmuth; Michael E Grigg; John Parkinson
Journal:  Mol Syst Biol       Date:  2013-11-19       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.